Initially considered specific for PTC diagnosis, RET/PTC is now identified in some benign disease like HT as detection sensitivity improves (58, 59).This process arises from chromosomal rearrangements that affect the MAPK signaling pathway and lead to its sustained activation (60). The gene discussed is RET; the disease is hematocrit.